Literature DB >> 7117808

Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51chromium-labeled erythrocytes and with the Haemoccult test.

P Herzog, K H Holtermüller, J Preiss, J Fischer, K Ewe, H J Schreiber, M Berres.   

Abstract

The quantitative determinations of fecal daily blood loss after intravenous administration of 51Cr-labeled erythrocytes in 44 patients with colonic polyps and in 11 controls were compared with the results of the daily performed Haemoccult test without dietary restrictions. A total of 642 stool specimens was analyzed for 51Cr loss and the Haemoccult test. The mean fecal daily blood loss in the 34 patients with adenomatous polyps of the descending colon and rectosigmoid was 1.36 +/- 0.14 ml/day (mean +/- SEM), in the 10 patients with polyps of the ascending and transverse colon it was 1.28 +/- 0.31 ml/day, and in the 11 controls 0.62 +/- 0.07 ml/day. There was no positive Haemoccult test in the controls. In fecal specimens from patients with polyps in the descending colon and rectosigmoid containing 2.0-3.99 ml blood/day, the Haemoccult-test was positive in 86%. Fecal specimens from patients with polyps in the ascending colon and transverse colon containing equal blood loss yielded a positive Haemoccult test result in 26%. Thus, the positivity of the Haemoccult test is determined by the fecal daily blood loss and the anatomic location of colonic bleeding sites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7117808

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  [Colonic neoplasms and skin fibromas: common determinants and their significance].

Authors:  A Leopolder-Ochsendorf; F R Ochsendorf; K H Tews; R Milbradt; P Herzog; K H Holtermüller
Journal:  Klin Wochenschr       Date:  1990-01-19

2.  [A new latex agglutination test for the immunologic detection of occult blood in stool].

Authors:  P Herzog; U König; K H Holtermüller
Journal:  Klin Wochenschr       Date:  1989-03-01

3.  Histopathological assessment of bleeding from polyps of the colon and rectum.

Authors:  A Waldock; I O Ellis; N C Armitage; D R Turner; J D Hardcastle
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

4.  Symposium: Screening for colorectal cancer.

Authors:  F Macrae; G Ekelund; B P Robra; R Gnauck; H Ribet; J Escourrou; J H Bond; N C Armitage; J B Simon
Journal:  Int J Colorectal Dis       Date:  1986-04       Impact factor: 2.571

Review 5.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  Effect of diet on fecal occult blood testing in patients with colorectal polyps.

Authors:  R G Norfleet
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

7.  Screening for colorectal cancer: sample techniques.

Authors:  R J Bridges; E A Shaffer
Journal:  Can Fam Physician       Date:  1988-03       Impact factor: 3.275

8.  Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.

Authors:  J Tibble; G Sigthorsson; R Foster; R Sherwood; M Fagerhol; I Bjarnason
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

Review 9.  Screening for colorectal cancer.

Authors:  S J Winawer; D Miller
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

10.  Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

Authors:  David A Ahlquist; Daniel J Sargent; Charles L Loprinzi; Theodore R Levin; Douglas K Rex; Dennis J Ahnen; Kandice Knigge; M Peter Lance; Lawrence J Burgart; Stanley R Hamilton; James E Allison; Michael J Lawson; Mary E Devens; Jonathan J Harrington; Shauna L Hillman
Journal:  Ann Intern Med       Date:  2008-10-07       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.